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Received February 16, 2012; accepted May 22, 2012AbstractBackground: Human immunodeficiency virus (HIV)-infected patients are at risk for bacterial and opportunistic infections with worsening
immunosuppression.
Methods: From June 2000 to January 2009, six patients who were diagnosed with HIV infection underwent 10 joint replacement procedures,
including six total hip arthroplasties, two total knee arthroplasties, and one shoulder hemiarthroplasty. An ordinary dose of postsurgical-
empirical antibiotics was prescribed, with an average follow-up period of 38.6 months. All prostheses of total knee arthroplasty and
shoulder hemiarthroplasty were fixed with vancomycin-impregnated bone cement.
Results: The rate of postoperative infection for HIV infected patients is supposed to be higher than for HIV negative patients. However, in our
institution, there have been no HIV- positive patients who have suffered postoperative infection.
Conclusion: HIV-positive patients can have excellent outcomes after undergoing various arthroplastic surgeries. This revelation, coupled with the
advances in antiviral therapy that have helped to lengthen HIV patient lifespans, strongly suggests that these patients should receive arthroplastic
surgery.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Human immunodeficiency virus (HIV) has been recognized
as an invasive medical entity for more than 20 years, and
a large number of articles have been published on the topic.
Common orthopedic problems among HIV-positive patients
include myopathy and arthropathy.1 The cause of these
orthopedic problems is either related to HIV-induced immu-
nodeficiency, or due to side effects of antiviral drugs.2
Osteonecrosis of the femoral head is the most common
orthopedic problem requiring surgical intervention. The inci-
dence of osteonecrosis in HIV-positive patients has increased* Corresponding author. Dr. Wei-Ming Chen, Department of Orthopaedics
and Traumatology, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai
Road, Taipei 112, Taiwan, ROC.
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http://dx.doi.org/10.1016/j.jcma.2012.08.021in recent years.3e6 Several reports revealed that osteonecrosis
of the femoral head was associated with highly active anti-
retroviral therapy (HAART), specifically protease inhib-
itors.7e9 The risks of performing arthroplasty on HIV-positive
patients include postoperative infection, contamination of
medical instruments, and HIV exposure to the medical team.
We performed a retrospective survey of the clinical
outcomes of all HIV-positive patients who had undergone
arthroplasty in our institution, and assessed the rate of post-
operative infection and functional recovery.2. Methods
Five HIV-positive patients who underwent a total of 9 joint
replacement surgeries [6 total hip replacements (THR), 2 total
knee arthroplasties (TKA), and 1 hemishoulder arthroplasty]
from September 2003 to May 2010 were studied. Thehinese Medical Association. All rights reserved.
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osteonecrosis of the femoral head (Ficat Stages III to IV)
(Fig. 1A). The diagnosis of the patient who underwent bilat-
eral TKA was advanced secondary inflammatory arthritis
(Fig. 2A,B). The patient who underwent hemishoulder
arthroplasty was diagnosed with a 3-part fracture-dislocation
of the humeral head (Fig. 3A,B). The mean age of these 5
patients was 44.5 years (range 36e54 years). All 5 patients
were male and had undergone antiviral therapy, with a mean
follow-up period of 38.6 months (range 4e84 months). The
patients’ general data are shown in Table 1.
These five patients were admitted to isolation wards.
Routine laboratory tests, including hematology, chemistry and
coagulability were performed, and active infection was ruled
out prior to surgery. All members of the medical team wore
protective suits with three layers of surgical gloves, without
self-contained breathing units. Skin preparation prior to
surgery was performed with hibiscrub and betadine alcohol,
and all surgical drapes were waterproof.
First-generation cephalosporins (Cefa Inj. 1 g IV; Taiwan
Biotech Co. Ltd, Taoyaun, Taiwan) were administered for
prophylaxis 30 minutes prior to the beginning of each surgery.
All nine joint replacement surgeries were performed by one
surgeon, and all surgical assistants were either senior residents
or nurses. No minimally-invasive surgery was performed on
any of the patients, and all surgeries were performed at the end
of the day to minimize the risk of spreading HIV.
The procedures performed were cementless THR (Fig. 1B),
vancomycin-impregnated cemented TKA (Fig. 2C,D), andFig. 1. (A) The patient was diagnosed with bilateral osteonecrosis of the
femoral head, Ficat stage III. (B) Cementless total hip replacement was
chosen. (C,D,E) 6-year postoperative follow-up: bilateral hip good function
without prosthesis loosening or malalignment.hemishoulder arthroplasty (Fig. 3C). The vancomycin
concentration was 1 g in 40 g of polymethylmethacrylate.
First-generation cephalosporins (Cefa Inj. 1 g IV) were
administered post-surgically every 6 hours for 3 days.
Furthermore, all medical waste was managed separately
during hospitalization. Early rehabilitation began the day after
surgery, with a mean period of hospitalization of 6 days (range
5e9 days). All five patients underwent regular outpatient
follow-up, with subsequent review of Harris hip scores, Knee
Society scores, and Constant scores used to evaluate function
recovery.
Consent of the citation of all medical records within the
study had been obtained from the patients.
3. Results
Postoperative complications, such as infection, prosthesis
loosening, limping, and neurovascular compromise were not
mentioned in any of the patient records. For THR, all patients
demonstrated obvious improvement in function. The mean pre-
and postoperative Harris hip scores were 46 (range 45e47), and
92.83 (range 92e94), respectively (Fig. 1CeE). For TKA, both
knees had excellent functional recovery after surgery
(Fig. 2E,F). The mean pre- and postoperative Knee Society
scores were 39.5 (41 and 38), and 92, respectively. For hemi-
shoulder arthroplasty, the patient was satisfied with the function
of his right shoulder (Fig. 3D,E), with a postoperative Constant
score of 85. The complete results are shown in Table 2.
4. Discussion
Individuals infected with HIV eventually develop acquired
immunodeficiency syndrome (AIDS), which is characterized
by frequent infections, neoplasms, and neurologic disorders.10
According to the literature, bacterial infection rates are
increased in HIV-infected patients who receive surgical
treatment.11 Teeuwsen et al described the presence of in vivo
immune system abnormalities 3 months following serocon-
version.12 Some researchers also reported that asymptomatic
HIV-positive patients with normal CD4 counts also have
selective depletion of CD29þ memory T cells, lower amounts
of viral DNA integration into host CD4þ cells, and decreased
cytotoxicity exhibited by monocytes and macrophages.13e15 In
addition to the immunodeficiency, the increased bacterial
infection rate might be attributable to poor wound healing.
Seltzer et al stated, “Patients with HIV disease are more
susceptible to postoperative complications, specifically
delayed healing, increased infection rates, and perhaps even
progression of their disease state.”16 HIV-positive patients may
have decreased wound healing ability because of a blunted
inflammatory response.16
In our study, only one patient had symptoms of immuno-
deficiency of recurrent bacterial enteritis. He underwent
bilateral TKA for the treatment of secondary inflammatory
arthritis. Prior to the operation, he was admitted for treatment
of infectious enteritis due to coagulase-negative Staphylo-
coccus, and completed a 7-day course of antibiotics. The other
Fig. 2. (A,B) The patient was diagnosed with bilateral advanced secondary inflammatory arthritis of the knee. (C,D) Vancomycin-impregnated cemented TKAwas
chosen. (E,F) 84 months of right knee and 7 month of left knee postoperative follow-up. Both knees had good clinical outcomes.
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patients were noted to have experienced postoperative infec-
tions in our study, which might reflect the advanced state of
antibiotics and antiviral agents, as well as the technical skills
of the surgeon.
Many studies have reported that arthropathies are associ-
ated with HIV infection and/or the antiviral agents. HIV-
associated arthritis most commonly affects the knees and
ankle,17e21 and one proposed etiology suggests a direct effect
of HIV on the joint.17,20 Another theory was that HIV-
associated arthritis might be related to the presence of
immune complexes within the synovium.17,18 In radiographicand advanced imaging studies, diffuse osteopenia and/or joint
effusions with or without erosive changes may be
identified.17,18,22
Another common orthopedic disorder among HIV-positive
patients is osteonecrosis of the femoral head, which may be
related to the use of protease inhibitors.23 Reports suggest that
altered lipid metabolism may result in emboli and bone
infarction, and that engorgement of marrow adipocytes may
lead to compression of the bone vasculature.24 In addition to
the drug effect, increased serum levels of anticardiolipin and
antiphospholipid antibodies might lead to an increased risk of
thromboembolic events, possibly resulting in osteonecrosis of
Fig. 3. (A,B) The patient was diagnosed with a right humeral head three-part fracture dislocation, but he was misdiagnosed at first and had delayed treatment. (C)
Vancomycin-impregnated cemented hemishoulder arthroplasty was chosen. (D,E) 73 month postoperative follow-up. The patient was satisfied with the right
shoulder functional recovery.
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the femoral head is common and may lead to an irreversible
condition. Inexperience on the part of HIV clinicians and lack
of awareness by patients often contribute to a delay in diag-
nosis. Pain syndromes are common among HIV-infected
patients, and the providers and patients might overlook the
severity of this condition.3 In our study, all five patients were
undergoing antiviral therapy. Three patients were diagnosed
with osteonecrosis of the femoral head, and one patient was
diagnosed with secondary inflammatory arthritis of both
knees. Musculoskeletal complaints were noted at least 6
months before their surgeries.
Many studies have described the increasing occupational
risks of HIV exposure for surgical healthcare workers, and
further reported the benefits of eye protection and double
gloving to help minimize these risks.32e34 Before the opera-
tions in our study, eye protection, protection suits, and triple
gloving were in place to minimize the risk of exposure to HIV.Table 1
The mean age of these patients was 44.5 years (range 36e54 years). All
patients were male and had undergone antiviral therapy. The mean follow-up
interval was 38.6 months (range 4e84 months).
No. Gender Age Procedure Symptoms
1 M 55 THR No
2 M 53 TKA Yes
3 M 54 Hemishoulder arthroplasty No
4 M 39 THR No
5 M 36 THR No
THR¼ total hip replacement; TKA¼ total knee arthroplasty.As a supplemental protective measure, waterproof drapes were
applied for a sterile surface. In addition to the protective
equipment, the assistants were all senior residents and nurses
familiar with these surgical procedures, which further lowered
the risk of HIV exposure. Given the variety and quality of
prudent protective measures in place, none of the members of
our surgical team had concerns about HIVexposure during any
of the surgeries.
In conclusion, since a greater number of orthopedic prob-
lems has been reported among HIV-positive patients, addi-
tional scrutiny is needed with regard to the surgical care
provided to these patients. Many clinicians might hesitate to
surgically treat HIV-positive patients due to concerns about the
risk of postoperative infection and the exposure to HIV for the
surgical healthcare team. However, advances in surgical
techniques, improved surgical instrumentation, and increas-
ingly effective antibiotics have reduced those concerns. The
excellent clinical outcomes of these HIV-positive patients who
received arthroplasty should indicate that, with the proper
precautions, necessary medical procedures can be safely per-
formed on HIV-positive patients, which can both prolong the
life of HIV patients, while not compromising the health of the
surgical teams involved. Advances in the use of antibiotics for
prevention of postoperative infection, improved surgical
techniques which promote better functional recovery, and the
longer lifespans of HIV patients due in large part to advances
in antiviral therapy all support the notion that surgical treat-
ment is appropriate, and functionally workable for these
patients.
Table 2
Surgical results. The mean follow-up interval was 38.6 months. The clinical results of all patients were improved significantly after the operation.
No Procedure Follow-up interval (mo) Preoperative score Postoperative score
Right Left Right Left Right Left
1 THR 71 71 45 46 92 93
2 TKA 84 7 41 38 92 92
3 Hemishoulder arthroplasty 73 85
4 THR 20 42 47 45 94 92
5 THR 4 8 46 47 93 93
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